Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0630

-1.6%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jm2i123 who wrote (11163)	4/23/2012 2:41:42 PM
From: Mammon	1 Recommendation Read Replies (1) of 13111

We don't have to give over the board to nattering negativism. I'd like to discuss subjects like what are the pros and cons of doing the phase III trials with or without a partner what a potential derm deal might look like how provectus compares to other biotech companies that have recently been bought out if there's any chance for accelerated approval given the Moffitt studies how the psoriasis results compare to other gels [not systemic treatments] how pv10 might work as a first defense drug. the pharmaceutical companies perception of pvct when does this company's stock price start to represent its true value? I just read an interesting article in this week's New Yorker about the resurgence of immunology in cancer treatment. We're on the cusp of something groundbreaking here, imho.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next